Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
4.500
-0.260 (-5.46%)
At close: Nov 19, 2026, 4:00 PM EST
4.240
-0.260 (-5.78%)
After-hours: Nov 19, 2026, 7:59 PM EST
Cue Biopharma Revenue
Cue Biopharma had revenue of $132.00K in the quarter ending September 30, 2026, a decrease of -93.86%. This brings the company's total for the last twelve months to $35.64M, up 401.93% year-over-year. In the year 2025, Cue Biopharma had annual revenue of $27.47M with 195.75% growth. That makes Cue Biopharma the 30,323rd largest company in the world by revenue and 4,000th in the United States.
Revenue (ttm)
$35.64M
Revenue Growth
+401.93%
P/S Ratio
0.91
Revenue / Employee
$1,228,897
Employees
29
Market Cap
32.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.47M | 18.18M | 195.75% |
| Dec 31, 2024 | 9.29M | 3.80M | 69.16% |
| Dec 31, 2023 | 5.49M | 4.25M | 340.96% |
| Dec 31, 2022 | 1.25M | -13.70M | -91.67% |
| Dec 31, 2021 | 14.94M | 11.79M | 373.68% |
| Dec 31, 2020 | 3.15M | -304.01K | -8.79% |
| Dec 31, 2019 | 3.46M | 2.32M | 202.67% |
| Dec 31, 2018 | 1.14M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Celularity | 18.67M |
| Immutep | 13.79M |
| Metagenomi Therapeutics | 7.09M |
| Lipocine | 3.74M |
| BeyondSpring | 1.88M |
| IGC Pharma | 1.11M |
| Cocrystal Pharma | 435.00K |
| CervoMed | 8.73K |
CUE News
- 1 day ago - Cue Biopharma price target lowered to $25 from $83 at B. Riley - TheFly
- 1 day ago - Cue selloff brings âattractive buying opportunity,â says Lucid Capital - TheFly
- 2 days ago - Cue Biopharma trading resumes - TheFly
- 2 days ago - Cue Biopharma trading halted, volatility trading pause - TheFly
- 3 days ago - Cue Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 days ago - Cue Biopharma Quarterly report: Q3 2026 - Filings
- 3 days ago - Cue Biopharma Earnings release: Q3 2026 - Filings
- 1 month ago - B. Riley would be âaggressive buyersâ of Cue Biopharma after selloff - TheFly